Search results for "recurrence"

showing 10 items of 1036 documents

[Current developments and perspectives on the diagnosis and treatment of urinary incontinence and genital prolapse in women].

2012

As a key area of gynaecology, urogynaecology has undergone impressive changes in the past few years. Together with the high prevalence of functional pelvic floor disorders, modern anaesthesia procedures and the introduction of new, innovative minimally invasive operation techniques have led to a dramatic increase in the number of operations for incontinence and prolapses. The increasingly subtle diagnostic options, such as, e. g., 2D and 3D sonography of the pelvic floor provide unambiguous findings and facilitate decision making. Tension-free vaginal slings in retro-pubic, trans-obturator or single-incision techniques show a high success rate with few complications and have almost complete…

Reoperationmedicine.medical_specialtyStress incontinenceUrinary Incontinence StressUrinary incontinencePelvic floor surgeryPelvic Floor DisordersArticleUrogynecologyImaging Three-DimensionalPostoperative ComplicationsRecurrenceUterine ProlapseGermanyMaternity and MidwiferyImage Interpretation Computer-AssistedmedicineHumansMinimally Invasive Surgical ProceduresSex organUltrasonographySuburethral SlingsPelvic floorHigh prevalencebusiness.industryGeneral surgeryObstetrics and GynecologySurgical Meshmedicine.diseaseSurgeryClinical trialmedicine.anatomical_structureFemaleClinical CompetenceCurriculummedicine.symptombusinessAktuelle Urologie
researchProduct

Imperative and Elective Indications for Nephron-Sparing Surgery for Renal Tumors: Long-Term Oncological Follow-Up

2010

INTRODUCTION: Nephron-sparing surgery (NSS) is mandatory for patients with renal tumors in both kidneys or in a solitary kidney in order to preserve renal function (imperative indication). NSS has also become the gold standard (elective indication) for small unilateral renal tumors (< 4 cm) with a normal contralateral kidney. We report the oncological long-term follow-up of NSS of our own series and discuss the results of the current literature. PATIENTS AND METHODS: From 1979 until 2006, a total of 851 patients was treated at our institu-tion by NSS. The mean tumor diameter was 3 cm (0.5-11 cm) for elective cases and 4.2 cm (1.2-11 cm) for imperative cases. The median follow-up for electiv…

Reoperationmedicine.medical_specialtyUrologySolitary kidneyRenal functionNephrectomyDisease-Free SurvivalNeoplasms Multiple PrimaryPostoperative ComplicationsRenal cell carcinomamedicineHumansCarcinoma Renal CellRetrospective StudiesTumor sizebusiness.industryGold standardNephronsmedicine.diseaseKidney NeoplasmsSurgeryElective Surgical ProceduresKidney Failure ChronicChronic renal failureBoth kidneysNephron sparing surgeryNeoplasm Recurrence LocalbusinessFollow-Up StudiesAktuelle Urologie
researchProduct

Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2013

Riskmedicine.medical_specialtyPalliative careColorectal cancermedicine.medical_treatmentColonoscopyAdenocarcinomaRisk AssessmentmedicineHumansNeoplasm MetastasisSigmoidoscopyWnt Signaling PathwayDigital Rectal ExaminationNeoplasm Stagingmedicine.diagnostic_testRectal Neoplasmsbusiness.industryGeneral surgeryCancerSigmoidoscopyChemoradiotherapyHematologymedicine.diseaseColorectal surgerySurgeryEuropeRadiation therapyOncologyNeoplasm Recurrence LocalbusinessColorectal SurgeryChemoradiotherapyFollow-Up StudiesAnnals of Oncology
researchProduct

Is routine second-look endoscopy effective after endoscopic hemostasis in acute peptic ulcer bleeding? A meta-analysis

2012

Background Routine second-look endoscopy in modern-era peptic ulcer bleeding (PUB) remains controversial. Objective To assess the effectiveness of routine second-look endoscopy in patients with PUB exhibiting high-risk stigmata after standard medical care and endoscopic therapy. Design Comprehensive literature searches (1990-2011) were performed, seeking randomized trials comparing a routine with an as-needed second endoscopy. Main Outcome Measurements The main outcome was rebleeding. Secondary outcomes were surgery and mortality. Subanalyses assessed the influence of study quality, rebleeding definitions, endoscopic hemostasis modality, and proton pump inhibitor (PPI) therapies. Analyses w…

Riskmedicine.medical_specialtymedicine.drug_classMEDLINEProton-pump inhibitorlaw.inventionRandomized controlled trialRecurrencelawOdds RatiomedicineHumansRadiology Nuclear Medicine and imagingModels Statisticalmedicine.diagnostic_testbusiness.industryHemostasis EndoscopicGastroenterologyProton Pump InhibitorsOdds ratioConfidence intervalSurgeryEndoscopyPeptic Ulcer HemorrhageTreatment OutcomeMeta-analysisHemostasisbusinessGastrointestinal Endoscopy
researchProduct

Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations : Results from a Multi-institutional European Retrospective Study

2022

[Purpose] The effect of high-dose imatinib (800 mg/day) on survival in the adjuvant treatment of patients with resected KIT exon 9–mutated gastrointestinal stromal tumors (GIST) is not established. Here, the association of dose and other clinicopathologic variables with survival was evaluated in a large multi-institutional European cohort.

STRUCTURAL BASISEXPRESSIONOncologyCancer Researchmedicine.medical_specialtyGastrointestinal Stromal Tumors3122 CancersMedizinAntineoplastic Agentsexon 9Adjuvants ImmunologicInternal medicinemedicineHumansFAILURERetrospective StudiesRISKRECEPTORGiSTProportional hazards modelbusiness.industryGASTROINTESTINAL STROMAL TUMORSHazard ratioImatinibRetrospective cohort studyExonsAdjuvant treatmentConfidence intervalGENOTYPEProto-Oncogene Proteins c-kitOncologyChemotherapy AdjuvantMutationPropensity score matchingCohortImatinib MesylateNeoplasm Recurrence LocalTYROSINE KINASE INHIBITORbusinessRare cancers Radboud Institute for Health Sciences [Radboudumc 9]medicine.drugGIST
researchProduct

Salivary levels of Tumour Necrosis Factor-alpha in patients with recurrent aphthous stomatitis

2010

Objetives: Recurrent aphthous stomatitis (RAS) is a common pathology of the oral mucosa with a complex and multifactorial etiology. Tumour Necrosis Factor-alpha (TNF?) is a cytokine with an important but not well-known role in the development of new lesions in RAS patients. Modifications of salivary levels of TNF? in RAS patients during the active periods of the disease have been measured in this work. The possible implication of TNF? in RAS etiology is also discussed. Study design: The study group was composed of 20 patients previously diagnosed with RAS and randomly selected. As a control group 10 healthy patients were also randomly selected. In both groups a TNF? assessment was carried o…

SalivaNecrosismedicine.medical_treatmentRecurrent aphthous stomatitisRecurrencemedicineHumansOral mucosaSalivaGeneral DentistryStomatitisTumor Necrosis Factor-alphabusiness.industrymedicine.disease:CIENCIAS MÉDICAS [UNESCO]medicine.anatomical_structureCytokineOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASImmunologyEtiologyStomatitis AphthousSurgerySample collectionmedicine.symptombusiness
researchProduct

Oncological Outcomes of Primary vs. Salvage OPHL Type II: A Systematic Review

2022

Background: Open partial horizontal laryngectomy type II (OPHL type II) has two main aims: oncological radicality and laryngeal preservation. The aim of this review is to define and emphasize the oncological efficacy of OPHL type II, both as primary and salvage surgery, by analyzing the latest literature. Methods: The research was carried out on Pubmed, Scopus and Web of Science databases, by using strict keywords. Oncological outcomes were evaluated by the following parameters: overall survival, disease-specific survival, disease-free survival, local control, laryngeal preservation, local recurrence. Results: The review included 19 articles divided into three groups: (1) primary OPHL type …

Salvage TherapyHealth Toxicology and MutagenesisRPublic Health Environmental and Occupational HealthLaryngectomyHead and neck; Laryngectomy; Otolaryngology; Salvage therapy; Surgical oncology; Disease-Free Survival; Humans; Laryngectomy; Neoplasm Recurrence Local; Retrospective Studies; Salvage Therapy; Treatment Outcome; Laryngeal NeoplasmsDisease-Free Survivalhead and necksurgical oncologyNeoplasm RecurrenceTreatment OutcomeSettore MED/31 - OtorinolaringoiatriaLocalotolaryngologyMedicineHumansNeoplasm Recurrence LocalLaryngeal NeoplasmsRetrospective Studies
researchProduct

Inguinal Hernia: Defect Obliteration with the 3D Dynamic Regenerative Scaffold Proflor™.

2021

Prosthetic inguinal hernia repair presents significant challenges. Some of these, such as mesh fixation and quality of the biologic response, are still debated among surgeons. For example, there is no strong consensus regarding a specific condition that characterizes the surgical procedure during herniorrhaphy. This issue concerns management of the hernia defect, which in conventional hernia repair with flat meshes remains patent. However, a critical analysis of typical postoperative complications after inguinal hernia repair reveals that some of these adverse events are related to patency of the hernial opening. Postoperative discomfort, pain with specific movements and even hernia recurre…

Scaffoldmedicine.medical_specialtyPain PostoperativeBiologic responsebusiness.industrymedicine.medical_treatmentProcedural approachHernia InguinalGeneral MedicineProstheses and ImplantsSurgical Meshmedicine.diseaseHernia repairGroinSurgeryMesh fixationInguinal herniaRecurrenceHernial openingmedicineHumansHerniabusinessHerniorrhaphySurgical technology international
researchProduct

Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience

2014

Background: Optimally, secondary cytoreduction is acknowledged as a valid option in terms of oncologic outcome for patients with platinum-sensitive recurrent ovarian cancer. In cases of localized relapse, a laparoscopic approach has been attempted at various institutions, but studies on its role for this subset of patients still are limited. This report describes the authors' experience using laparoscopic secondary cytoreduction for patients with localized recurrent ovarian cancer. The results from a retrospective analysis of a prospective case series are reported. Methods: Between October 2011 and May 2013, 29 patients with localized recurrent ovarian cancer were selected for a laparoscopi…

Secondary cytoreductionmedicine.medical_treatmentTissue AdhesionsPostoperative ComplicationsLaparotomyLaparoscopyOvarian Neoplasmsmedicine.diagnostic_testMedicine (all)Middle Agedovarian cancerChemotherapy AdjuvantLymphatic MetastasisFemaleAdult; Aged; Antineoplastic Agents; Carcinoma; Chemotherapy; Adjuvant; Disease-Free Survival; Female; Follow-Up Studies; Humans; Laparoscopy; Laparotomy; Length of Stay; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Monitoring; Intraoperative; Neoplasm Recurrence; Local; Neoplasm Staging; Operative Time; Ovarian Neoplasms; Postoperative Complications; Retrospective Studies; Tissue AdhesionsAdultmedicine.medical_specialtyRecurrent ovarian cancer; Laparoscopy; Secondary cytoreductionOperative TimeAntineoplastic AgentsDisease-Free SurvivalLaparoscopicMonitoring IntraoperativeInternal medicineCarcinomamedicineHumansAgedNeoplasm StagingRetrospective StudiesLaparotomybusiness.industryGeneral surgeryCarcinomaRetrospective cohort studyLength of StayHepatologymedicine.diseaseSurgerySettore MED/40 - GINECOLOGIA E OSTETRICIARecurrent Ovarian CancerLymph Node ExcisionSurgeryLaparoscopyNeoplasm Recurrence LocalRecurrent ovarian cancerOvarian cancerbusinessFollow-Up StudiesAbdominal surgery
researchProduct

Unmet needs and gaps in the identification of secondary progression in multiple sclerosis: a Southern Italy healthcare professionals' perspective

2022

Abstract Objective Multiple sclerosis (MS) is a chronic disease with different clinical courses and a tendency to worsening. The relapsing–remitting MS presents acute onset and relapses of neurological symptoms, followed by their remission. This form can convert to secondary progressive MS (SPMS) with irreversible neurological worsening and disability. The identification of signs, symptoms, markers of progression, and strategies to manage MS patients is mandatory to allow early identification of those at higher risk of conversion to SPMS, for prompt intervention to cope with the progression of the disease. Methods A panel of Italian experts from Southern Italy have reviewed the current know…

Secondary progressive multiple sclerosis (SPMS)DermatologyGeneral MedicineBiomarkerMultiple Sclerosis Chronic ProgressiveMultiple sclerosisPsychiatry and Mental healthMultiple Sclerosis Relapsing-RemittingItalyExpert opinionDiagnosisQuality of LifeDisease ProgressionHumansMultiple sclerosiSettore MED/26 - NeurologiaNeurology (clinical)Neoplasm Recurrence LocalAtrophyDelivery of Health CareBiomarkersDiagnosi
researchProduct